Anebulo Pharmaceuticals I...
(ANEB)
undefined
undefined%
At close: undefined
1.40
-3.11%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 |
Cash & Equivalents | 3.09M | 11.25M | 14.55M | 19.99M | 3.02M |
Short-Term Investments | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - |
Other Long-Term Assets | 565.12K | - | - | - | - |
Receivables | - | - | - | - | 3.50K |
Inventory | - | - | - | - | -3.5 |
Other Current Assets | 413.79K | 422.75K | 1.03M | 1.67M | - |
Total Current Assets | 3.51M | 11.25M | 14.55M | 19.99M | 3.03M |
Property-Plant & Equipment | - | - | - | - | - |
Goodwill & Intangibles | - | - | - | - | - |
Total Long-Term Assets | 565.12K | - | 1.03M | 1.67M | - |
Total Assets | 4.07M | 11.67M | 15.58M | 21.65M | 3.03M |
Account Payables | 156.43K | 534.54K | 380.83K | 110.05K | - |
Deferred Revenue | - | - | - | - | - |
Short-Term Debt | - | - | - | - | 201.29K |
Other Current Liabilities | 104.16K | 534.26K | 131.70K | 131.59K | 22.58K |
Total Current Liabilities | 260.58K | 534.54K | 512.53K | 241.63K | 223.87K |
Long-Term Debt | - | - | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - |
Total Long-Term Liabilities | - | 534.26K | 380.83K | 131.59K | 2.98M |
Total Liabilities | 260.58K | 1.07M | 512.53K | 241.63K | 3.20M |
Total Debt | - | - | - | - | 201.29K |
Common Stock | 25.93K | 25.63K | 23.34K | 23.34K | 12.00K |
Retained Earnings | -65.40M | -57.20M | -45.47M | -38.64M | -183.14K |
Comprehensive Income | - | 0.00 | - | -21.65M | -2.99M |
Shareholders Equity | 3.81M | 10.60M | 15.07M | 21.41M | -171.14K |
Total Investments | - | - | - | - | - |